A Caregiver's Perspective on Male Breast Cancer in India: Stigma, Disclosure, and the Lived Experience
1Department of Sociology, Presidency University, Kolkata, West Bengal 700073, India.
Abstract:
Male breast cancer (MBC), a comparatively rare type of malignancy, is often diagnosed very late with extremely poor prognosis and early deaths of the patients, largely due to cultural stigma and societal taboo surrounding masculinity, and limited healthcare awareness. My experience as a caregiver for a distant relative from a rural village in West Bengal, India, whose stage-IV MBC was detected after a 15-month delay and early demise, exposed the profound impact of cultural expectations and shame on delayed diagnosis, patient outcomes, and heavy family burden. Our journey unveiled more challenges, such as family nondisclosure, social isolation, and extreme emotional distress stemming from the management of a cancer that is culturally perceived as feminine. This perspective emphasizes critical shortcomings in Male Breast Cancer awareness and care, highlighting the urgent need for culturally responsive education, family-centered counseling to alleviate shame and stigma, and policy reforms to enable earlier diagnosis and sustained and compassionate support for patients and caregivers.
Related Concept Videos
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Cancer Prevention
Some...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...


